S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
Log in
ASX:SIL

Smiles Inclusive Limited (SIL.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume54,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Smiles Inclusive Limited engages in the operation and acquisition of dental practices in Australia. The company offers various general, family, and specialist dental services. It operates a network of 56 dental practices under the Totally Smiles brand. The company was incorporated in 2017 and is based in West Burleigh, Australia.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.38 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolASX:SIL
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.smilesinc.com.au
Phone617 55668 7645
EmployeesN/A

Debt

Debt-to-Equity Ratio700.99
Current Ratio2.34
Quick Ratio2.06

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$36.48 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow1.67
Book ValueA($0.05) per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

Receive SIL News and Ratings via Email

Sign-up to receive the latest news and ratings for SIL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Smiles Inclusive Limited (SIL.AX) (ASX:SIL) Frequently Asked Questions

What stocks does MarketBeat like better than Smiles Inclusive Limited (SIL.AX)?

Wall Street analysts have given Smiles Inclusive Limited (SIL.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Smiles Inclusive Limited (SIL.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Smiles Inclusive Limited (SIL.AX)'s earnings last quarter?

Smiles Inclusive Limited (SIL.AX) (ASX:SIL) posted its quarterly earnings data on Thursday, February, 28th. The company reported ($0.03) earnings per share for the quarter.
View Smiles Inclusive Limited (SIL.AX)'s earnings history.

Who are some of Smiles Inclusive Limited (SIL.AX)'s key competitors?

Some companies that are related to Smiles Inclusive Limited (SIL.AX) include (BUX) (BUX), 12144 (IME), BARD1 Life Sciences Limited (BD1.AX) (BD1), Charles River Laboratories International (CRL), Cryosite Limited (CTE.AX) (CTE), dorsaVi Ltd (DVL.AX) (DVL), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Genetic Signatures Limited (GSS.AX) (GSS), Genetic Technologies Limited (GTG.AX) (GTG), Imagion Biosystems Limited (IBX.AX) (IBX), Integral Diagnostics Limited (IDX.AX) (IDX), Lifespot Health Ltd (LSH.AX) (LSH), Medical Imaging (MEDD) and OncoSil Medical Limited (OSL.AX) (OSL).
View all competitors.

Who are Smiles Inclusive Limited (SIL.AX)'s key executives?

Smiles Inclusive Limited (SIL.AX)'s management team includes the following people:
  • Ms. Michelle Aquilina, CEO, MD & Director
  • Mr. Mark O'Brien, Chief Operating Officer
  • Andrew Ritter, Company Sec.

What is Smiles Inclusive Limited (SIL.AX)'s stock symbol?

Smiles Inclusive Limited (SIL.AX) trades on the ASX under the ticker symbol "SIL."

How big of a company is Smiles Inclusive Limited (SIL.AX)?

Smiles Inclusive Limited (SIL.AX) has a market capitalization of $0.00 and generates $36.48 million in revenue each year.

What is Smiles Inclusive Limited (SIL.AX)'s official website?

The official website for Smiles Inclusive Limited (SIL.AX) is www.smilesinc.com.au.

How can I contact Smiles Inclusive Limited (SIL.AX)?

The company can be reached via phone at 617 55668 7645.

This page was last updated on 11/27/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.